胺碘酮在预激综合征并阵发性室上性心动过速中的应用效果分析

Clinical efficacy analysis of amiodarone on pre-excitation syndrome complicated with paroxysmal supraventricular tachycardia

目的探讨胺碘酮治疗预激综合征合并阵发性室上性心动过速的临床效果。方法选择本院2009年11月～2011年11月预激综合征合并阵发性室上性心动过速患者36例,上述患者给予胺碘酮治疗。观察本组患者治疗前后心率、血压、心功能、血钾等的改变情况,评定治疗后的临床效果。结果本组患者治疗后显效16例,有效17例,无效3例,总有效率为91.7%。本组患者治疗后收缩压、舒张压、心搏量、心排出量、左室射血分数、血钾水平与治疗前比较,差异无统计学意义(P>0.05);治疗后心率较治疗前显著降低,差异有统计学意义(P<0.05)。结论胺碘酮治疗预激综合征并阵发性室上性心动过速临床效果显著,值得借鉴。

Objective To explore the clinical efficacy of amiodarone on pre-excitation syndrome complicated with paroxysmal supraventricular tachycardia. Methods Thirty-six cases with pre-excitation syndrome complicated with paroxysmal supraventricular tachycardia were selected from November 2009 to November 2011. Amiodarone was given to all patients, blood pressure, heart rate, cardiac output, left ventricular function, serum potassium were detected before and after treatment. The clinical efficacy was evaluated after treatment. Results After treatment, there were 16 cases with marked effect, 17 cases with effectivess, 3 cases with no-effect and the total effective rate was 91.7%. The blood pressure, cardiac output, left ventricular function, serum potassium after treatment compared with those before treatment, there was no statistical difference （P 0.05）; the heart rate after treatment compared with that before treatment, there was statistical difference （P 0.05）. Conclusion Amiodarone on pre-excitation syndrome complicated with paroxysmal supraventricular tachycardia has significantly clinical efficacy, and the therapy should be the reference for doctors.